PMID- 26970976
OWN - NLM
STAT- MEDLINE
DCOM- 20180326
LR  - 20181202
IS  - 1178-1661 (Electronic)
IS  - 1178-1653 (Linking)
VI  - 9
IP  - 5
DP  - 2016 Oct
TI  - Development and Psychometric Evaluation of the Hypoglycemia Perspectives 
      Questionnaire in Patients with Type 2 Diabetes Mellitus.
PG  - 395-407
LID - 10.1007/s40271-016-0163-2 [doi]
AB  - AIMS: The aim of this study was to evaluate the factor structure and psychometric 
      characteristics of the Hypoglycemia Perspectives Questionnaire (HPQ) assessing 
      experience and perceptions of hypoglycemia in patients with type 2 diabetes 
      mellitus (T2DM). METHODS: HPQ was administered to adults with T2DM in a clinical 
      sample from Cyprus (HYPO-Cyprus, n = 500) and a community sample in the United 
      States (US, n = 1257) from the 2011 US National Health and Wellness Survey. 
      Demographic and clinical data were collected. Analysis of HPQ data from two 
      convenience samples examined item performance, factor structure, and HPQ 
      measurement properties (reliability, convergent validity, known-groups validity). 
      RESULTS: Analyses supported three HPQ domains: symptom concern (six items), 
      compensatory behavior (five items), and worry (five items). Internal consistency 
      was high for all three domains (all >/=0.75), supporting reliability. Convergent 
      validity was supported by moderate Spearman correlations between HPQ domain 
      scores and the Audit of Diabetes-Dependent Quality of Life (ADDQoL-19) total 
      score. Patients with recent hypoglycemia events had significantly higher HPQ 
      scores, supporting known-group validity. CONCLUSIONS: HPQ may be a valid and 
      reliable measure capturing the experience and impact of hypoglycemia and useful 
      in clinical trials and community-based settings.
FAU - Kawata, Ariane K
AU  - Kawata AK
AD  - Outcomes Research, Evidera, 7101 Wisconsin Avenue Suite 1400, Bethesda, MD, 
      20814, USA. ariane.kawata@evidera.com.
FAU - Wilson, Hilary
AU  - Wilson H
AD  - Outcomes Research, Evidera, 7101 Wisconsin Avenue Suite 1400, Bethesda, MD, 
      20814, USA.
FAU - Ong, Siew Hwa
AU  - Ong SH
AD  - Novartis Pharma AG, Basel, Switzerland.
FAU - Kulich, Karoly
AU  - Kulich K
AD  - Novartis Pharma AG, Basel, Switzerland.
FAU - Coyne, Karin
AU  - Coyne K
AD  - Outcomes Research, Evidera, 7101 Wisconsin Avenue Suite 1400, Bethesda, MD, 
      20814, USA.
LA  - eng
PT  - Journal Article
PL  - New Zealand
TA  - Patient
JT  - The patient
JID - 101309314
SB  - IM
MH  - Diabetes Mellitus, Type 2/*psychology
MH  - Humans
MH  - Hypoglycemia/*psychology
MH  - Psychometrics
MH  - *Quality of Life
MH  - Reproducibility of Results
MH  - Surveys and Questionnaires
EDAT- 2016/03/14 06:00
MHDA- 2018/03/27 06:00
CRDT- 2016/03/14 06:00
PHST- 2016/03/14 06:00 [entrez]
PHST- 2016/03/14 06:00 [pubmed]
PHST- 2018/03/27 06:00 [medline]
AID - 10.1007/s40271-016-0163-2 [pii]
AID - 10.1007/s40271-016-0163-2 [doi]
PST - ppublish
SO  - Patient. 2016 Oct;9(5):395-407. doi: 10.1007/s40271-016-0163-2.